Company news

Dyadic International, Inc. news in 2021

Dyadic International, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Dyadic Announces a NIIMBL Coronavirus Grant Under the White House’s American Rescue Plan

December 21, 2021

Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform

December 16, 2021

Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress

November 9, 2021

Dyadic Appoints Chief Business Officer to Executive Leadership Team

November 8, 2021

Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

August 11, 2021

Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics

August 10, 2021

Dyadic to Report Second Quarter 2021 Financial Results

July 28, 2021

Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent

July 26, 2021

Dyadic announces development of COVID-19 Vaccine in India

May 25, 2021

Dyadic Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress

May 12, 2021

Dyadic to Report First Quarter 2021 Financial Results

April 28, 2021

Dyadic Reports 2020 Year End Results and Recent Company Progress

March 29, 2021

UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine candidate, DYAI-100, Towards Human Clinical Trial

March 28, 2021

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

March 21, 2021

Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100

March 17, 2021

Dyadic to Report Fourth Quarter and Full Year 2020 Financial Results

March 15, 2021

Dyadic Enters Collaboration with TurtleTree Scientific to Develop Recombinant Protein Growth Factors

February 1, 2021

Dyadic International Appoints New Board Member

January 10, 2021

Calls in 2021

Decks in 2021